Director of Public Affairs, Jennifer Walsh was quoted in a Law360 article, “5 Key Takeaways from Senate’s ACA Repeal Bill,” covering criticisms against the Affordable Care Act repeal bill from both conservatives and insurance industry experts.
Republicans plan to pass the repeal bill, also known the Better Care Reconciliation Act (BCRA), as budget reconciliation with a simple majority. However, the BCRA provisions must pass the Byrd rule, which prohibits ‘extraneous matters,’ including provisions with budgetary effects that are ‘merely incidental’ to the provision in question.’
Walsh notes that much of the BCRA content “historically would not have passed the Byrd rule.”
Republicans plan to pass the repeal bill, also known the Better Care Reconciliation Act (BCRA), as budget reconciliation with a simple majority. However, the BCRA provisions must pass the Byrd rule, which prohibits ‘extraneous matters,’ including provisions with budgetary effects that are ‘merely incidental’ to the provision in question.’
Walsh notes that much of the BCRA content “historically would not have passed the Byrd rule.”
People
Related News
26 September 2024
In the News
Gregory Marino on NIL Litigation – 'Schools want to know where the line is, and now everything is in flux'
Foley & Lardner LLP special counsel Gregory Marino shared insight on the growing complexities of collegiate sports in the ABA Journal article, "Money and litigation tangle with recent rules for college athletes' NIL deals."
24 September 2024
In the News
Thomas Ferrante Assesses Recent HHS OIG Report on Remote Patient Monitoring
Foley & Lardner LLP partner Thomas Ferrante commented on the recently released report on remote patient monitoring from the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Fierce Healthcare article, “HHS watchdog flags potential remote monitoring fraud. Stakeholders say concerns about misuse are overblown.”
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."